Abstract:The relationships between degrees of chronic kidney disease (CKD) and congestive heart failure (CHF) events after percutaneous coronary intervention (PCI) are not well characterized. We sought to determine the relationship between different stages of CKD and acute CHF events, including heart failure (HF) and cardiogenic shock (CS), and the impact of CKD stages on all-cause mortality after PCI. Patients who underwent PCI from 2009-2017 were identified from our institution's National Cardiovascular Disease Registry (NCDR) CathPCI Database. Patients were stratified by CKD stage 1 (eGFR≥90 ml/min/1.73 m 2 ), 2 (60-89), 3a (45-59), 3b (30-44), 4 (16-29), 5 (≤15), and current dialysis. The primary endpoint was composite HF events defined as acute HF or CS within 30 days after PCI, or in-hospital mortality, stratified by CKD and analyzed by multivariable regression after screening with univariate analysis (P<0.05 entry criteria). Patients with CKD stage 3a or worse had more composite HF events, with an increase in all components, compared to patients with CKD stages 1-2 (P<0.0001 for all comparisons). After multivariable adjustment, CKD stages 3a-5 remained independent predictors of composite HF or in-hospital mortality events. eGFR remained a strong predictor of acute HF events after multivariable adjustment, with a model including eGFR and baseline and procedural characteristics achieving excellent discriminatory ability with AUC 0.92. In conclusion, baseline eGFR is a strong, independent predictor of acute HF events post-PCI. CKD stages 3a-5 independently predict HF events including HF decompensation and CS, and are predictors of in-hospital mortality post-PCI. Patients with baseline CKD may benefit from targeted interventions to limit acute HF events after PCI.

Chronic Kidney Disease Predisposes to Acute Congestive Heart Failure, Cardiogenic Shock, and Mortality in Patients Undergoing Percutaneous Coronary Intervention